Does J2850 require prior authorization?

No, J2850 does not require prior authorization (high confidence). Covered without prior authorization.

What is the Medicare reimbursement rate for J2850?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

Backwork Sign up free

`J2850`, Injection, secretin, synthetic, human, 1 microgram

HCPCS/CPT

Prior Authorization

No Prior Auth Required

Covered without prior authorization (high confidence)

Medicare Pricing

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Documentation Required

Documentation that developmental delays or persistent deficits in social communication and social interaction across multiple contexts have been identified to justify ASD evaluation and diagnosis.
Evidence that the evaluation was performed by an appropriate certified/licensed health care professional (e.g., board certified behavioral analyst, developmental pediatrician, neurologist, occupational therapist, physical therapist, primary care provider, psychiatrist, psychologist, speech-language pathologist, audiologist).

Use of standardized parent interviews and direct, structured behavioral observation as part of diagnostic assessment; documentation of instruments used when applicable (e.g., Autism Diagnostic Interview-Revised (ADI-R), Autism Diagnostic Observation Schedule-2 (ADOS-2), Childhood Autism Rating Scale-2 (CARS-2), Asperger Syndrome Diagnostic Scale).

Results and interpretation of developmental/intelligence testing with separate verbal and nonverbal estimates when performed.

For audiologic testing: documentation of formal audiological hearing evaluation results, including use/results of frequency-specific brainstem auditory evoked response or otoacoustic emissions when performed.

For lead testing: note documenting developmental delay with pica or high-risk environment and results of quantitative lead level assays.

Key Coverage Criteria

Comparative genomic hybridization (CGH) when medical necessity criteria are met (see CPB 0787).
Complete medical evaluation including medical history and physical examination, including neurologic evaluation.
Parent and/or child interview (including siblings of children with autism).
Quantitative plasma amino acid assays to detect phenylketonuria.
Selective metabolic testing when the child exhibits any of the following: cyclic vomiting, recurrent vomiting and dehydration; early seizure; lethargy; hearing impairment; hypotonia; visual impairment; unusual odor; dysmorphic or coarse features; evidence of mental retardation or mental retardation cannot be ruled out; or occurrence/adequacy of newborn screening for a birth defect is questionable.
Genetic counseling for parents of a child with autism.

1 Active Policy

AETNA-CPB-0648, Autism Spectrum Disorders

Have a follow-up question?

Ask Backwork about documentation requirements, denial risks, or coverage in your state.

Ask Backwork about J2850 Sign up free

J2850, Injection, secretin, synthetic, human, 1 microgram